Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. National Cancer Institute of the National Institutes of Health [U10CA180888, U10CA180819, U10CA180828, U10CA180821, U10CA13612, U10CA11083]
2. GlaxoSmithKline plc
3. NATIONAL CANCER INSTITUTE [U10CA011083, U10CA013612, U10CA180828, U10CA180819, U10CA180888, U10CA180821] Funding Source: NIH RePORTER